| # | Drug | Count |
|---|---|---|
| 0 | DENOSUMAB | 9 |
| 1 | APREPITANT | 8 |
| 2 | BEVACIZUMAB | 8 |
| 3 | CISPLATIN | 8 |
| 4 | PEGFILGRASTIM | 8 |
| 5 | PEMETREXED DISODIUM | 8 |
| 6 | ADALIMUMAB | 7 |
| 7 | ALCOHOL | 7 |
| 8 | ETHYL ALCOHOL | 7 |
| 9 | ISOPROPYL ALCOHOL | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | APREPITANT | 8 | 0.0011 |
| 1 | PEGFILGRASTIM | 8 | 0.0007 |
| 2 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 1 | 0.0004 |
| 3 | VUTRISIRAN | 1 | 0.0003 |
| 4 | ETHYL ALCOHOL | 7 | 0.0003 |
| 5 | ISOPROPYL ALCOHOL | 7 | 0.0002 |
| 6 | PEMETREXED DISODIUM | 8 | 0.0002 |
| 7 | PITAVASTATIN CALCIUM | 2 | 0.0002 |
| 8 | ALCOHOL | 7 | 0.0002 |
| 9 | MINOCYCLINE | 2 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 8 | 0.0009 |
| 1 | Barbiturate [EPC] | 1 | 0.0001 |
| 2 | Interleukin-17A Antagonist [EPC] | 3 | 0.0001 |
| 3 | Leukocyte Growth Factor [EPC] | 8 | 0.0001 |
| 4 | RANK Ligand Inhibitor [EPC] | 9 | 0.0000 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 8 | 0.0000 |
| 6 | Alkaloid [EPC] | 1 | 0.0000 |
| 7 | Parathyroid Hormone-Related Peptide Analog [EPC] | 1 | 0.0000 |
| 8 | Platinum-based Drug [EPC] | 8 | 0.0000 |
| 9 | Integrin Receptor Antagonist [EPC] | 2 | 0.0000 |